Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Active not recruiting 3Terminated 1Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 4Neoplasm Metastasis 2Lung Neoplasms 2Gliosarcoma 2Glioblastoma 2Brain Neoplasms 2Adenocarcinoma of Lung 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Stomach Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Nausea 1Melanoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Endometrial Serous Adenocarcinoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Docetaxel 56Prednisone 36enzalutamide 25Leuprolide 24Magnetic Resonance Spectroscopy 19Abiraterone Acetate 19bicalutamide 17Radiotherapy 15Goserelin 15abiraterone 12acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 11olaparib 9Androgen Antagonists 9gallium 68 PSMA-11 8cabazitaxel 8Radiotherapy, Intensity-Modulated 8Metformin 8Ketoconazole 8Gonadotropin-Releasing Hormone 8Cyclophosphamide 8apalutamide 7Doxorubicin 7luprolide acetate gel depot 6cabozantinib 6Radiosurgery 6Estramustine 6Dexamethasone 6Calcitriol 6Biopsy 6pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Prostatic Neoplasms × Radiotherapy, Conformal × Clear all
NCT00949962 2014-07-04

Post-operative or Early Salvage XRT and ADT for High Risk PCa

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
87 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡